2021
DOI: 10.1111/cup.14080
|View full text |Cite
|
Sign up to set email alerts
|

A rare case of syringocystadenocarcinoma papilliferum of the breast: An institutional retrospective case review and brief literature review

Abstract: Syringocystadenocarcinoma papilliferum (SCACP) is a rare cutaneous adnexal tumor thought to originate from its benign counterpart, syringocystadenoma papilliferum.These tumors are predominantly located on the head and neck with their location on the breast extraordinarily reported; mammary localization poses a great diagnostic dilemma to the practicing pathologist. Herein, we report an unusual case of an 85-year-old woman with an outside diagnosis on a core needle biopsy of metaplastic mammary carcinoma. Upon … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…While SCAP is a benign tumor, syringocystadenocarcinoma papilliferum (SCACP), the malignant counterpart, should be considered. In adults, the majority of SCACP have been reported on the head and neck region with extraordinary reports of SCACP to the breast and vulva 8,9 . Of the cases reported, approximately 17% of head and neck lesions resulted in metastatic progression 10 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While SCAP is a benign tumor, syringocystadenocarcinoma papilliferum (SCACP), the malignant counterpart, should be considered. In adults, the majority of SCACP have been reported on the head and neck region with extraordinary reports of SCACP to the breast and vulva 8,9 . Of the cases reported, approximately 17% of head and neck lesions resulted in metastatic progression 10 .…”
Section: Discussionmentioning
confidence: 99%
“…In adults, the majority of SCACP have been reported on the head and neck region with extraordinary reports of SCACP to the breast and vulva. 8,9 Of the cases reported, approximately 17% of head and neck lesions resulted in metastatic progression. 10 Cases of SCACP in pediatric patients have not been reported.…”
Section: Discussionmentioning
confidence: 99%